Default: Neoplasia

ISSN: 1522-8002

Journal Home

Journal Guideline

Neoplasia Q1 Unclaimed

Neoplasia Press United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neoplasia is a journal indexed in SJR in Cancer Research with an H index of 129. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2250 €. The scope of the journal is focused on cancer, tumors, oncology research, medicine. It has an SJR impact factor of 2,52 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,52.

Neoplasia focuses its scope in these topics and keywords: gene, cancer, promotes, gastric, breast, cell, malignant, lon, line, lapatinibresistant, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

DOAJ Scopus WOS
Categories: Cancer Research (Q1)
Price

2250 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Neoplasia

2,52

SJR Impact factor

129

H Index

72

Total Docs (Last Year)

308

Total Docs (3 years)

3572

Total Refs

2245

Total Cites (3 years)

308

Citable Docs (3 years)

5,17

Cites/Doc (2 years)

49,61

Ref/Doc

Aims and Scope


gene, cancer, promotes, gastric, breast, cell, malignant, lon, line, lapatinibresistant, mediates, metastatic, micewidespread, mmtvneut, modelenhanced, modifications, molecular, ncih, intrahepatic, hybridizationfibroblastic, human, cells, characterization, cholangiocarcinoma, chromosome, contributes, fluorescence, formation, fusion, glioma, growth, helicobacter, htert, cancer, tumors, oncology research, medicine



Best articles by citations

Tumor-Targeted Hyaluronan Nanoliposomes Increase the Antitumor Activity of Liposomal Doxorubicin in Syngeneic and Human Xenograft Mouse Tumor Models

View more

Profile - American Cancer Society

View more

Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1

View more

The Cure for Lymphoma Foundation

View more

Inhibition of Tumor Growth, Angiogenesis, and Microcirculation by the Novel Flk-1 Inhibitor SU5416 as Assessed by Intravital Multi-fluorescence Videomicroscopy

View more

The National Brain Tumor Foundation: Giving Help, Giving Hope

View more

Concern Foundation: Funding Cancer Research Worldwide

View more

American Brain Tumor Association: Sharing Knowledge, Sharing Hope

View more

Aberrant Methylation of the Maspin Promoter Is an Early Event in Human Breast Cancer

View more

National Childhood Cancer Foundation

View more

The International Myeloma Foundation

View more

Art Of The Brain: UCLA Neuro-Oncology Program

View more
SHOW MORE ARTICLES

The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate

View more

National Foundation for Cancer Research

View more

Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells in Human Renal Cell Carcinoma Is a Primary Target for Therapy by Tyrosine Kinase Inhibitors

View more

The G&P Foundation for Cancer Research

View more

Kidney Cancer Association

View more

The Association for International Cancer Research

View more

Neoplasia profile: American Institute for Cancer Research

View more

Neoplasia: Where We Have Been and Where We Are Going

View more

The V Foundation for Cancer Research

View more

Implications of Mapping the Human Telomerase Gene (hTERT) as the Most Distal Gene on Chromosome 5p

View more

Editorial

View more

Comments

No comments ... Be the first to comment!

FAQS